Solventum Corp stock hits 52-week high at 88.21 USD

Solventum Corp's stock has reached a 52-week high of $88.21, reflecting positive investor sentiment and a 20.57% increase over the past year. The healthcare technology firm, with a market capitalization of $14.92 billion, reported strong Q1 2026 earnings, surpassing expectations, and received an Outperform rating from Wedbush due to multiple growth catalysts. BTIG also maintained a Buy rating on Solventum, highlighting the evolving landscape of the healthcare and medical device industries.